Ahmadi Y, Faiq T, Abolhasani S
Mol Biol Rep. 2025; 52(1):230.
PMID: 39951181
DOI: 10.1007/s11033-025-10351-3.
He J, Dong C, Song X, Qiu Z, Zhang H, Jiang Y
Biol Direct. 2025; 20(1):9.
PMID: 39833962
PMC: 11744867.
DOI: 10.1186/s13062-025-00597-z.
Foffano L, Cucciniello L, Nicolo E, Migliaccio I, Noto C, Reduzzi C
Breast. 2024; 79:103863.
PMID: 39718288
PMC: 11872392.
DOI: 10.1016/j.breast.2024.103863.
Kang D, Wang X, Chen W, Mao L, Zhang W, Shi Y
Burns Trauma. 2024; 12:tkae047.
PMID: 39687464
PMC: 11647520.
DOI: 10.1093/burnst/tkae047.
Moon D
Int J Mol Sci. 2024; 25(5).
PMID: 38474160
PMC: 10932100.
DOI: 10.3390/ijms25052911.
Targeting NF-κB signaling cascades of glioblastoma by a natural benzophenone, garcinol, via and molecular docking approaches.
Danish Rizvi S, Almazni I, Moawadh M, Alharbi Z, Helmi N, Alqahtani L
Front Chem. 2024; 12:1352009.
PMID: 38435669
PMC: 10904546.
DOI: 10.3389/fchem.2024.1352009.
TREM1 as a novel prognostic biomarker and tumor immune microenvironment evaluator in glioma.
Lu Q, Xie Y, Qi X, Yang S
Medicine (Baltimore). 2023; 102(48):e36410.
PMID: 38050264
PMC: 10695587.
DOI: 10.1097/MD.0000000000036410.
RSK2 promotes melanoma cell proliferation and vemurafenib resistance upregulating cyclin D1.
Wu H, Li L, Jiang S, Li Y, Shi X, Sun X
Front Pharmacol. 2022; 13:950571.
PMID: 36210843
PMC: 9541206.
DOI: 10.3389/fphar.2022.950571.
Genome-wide comparison and analysis of splicing factor SYF2/NTC31/p29 in eukaryotes: Special focus on vertebrates.
Huang B, Jia Z, Yang X, Cheng C, Liu X, Zhang J
Front Genet. 2022; 13:873869.
PMID: 36118875
PMC: 9479762.
DOI: 10.3389/fgene.2022.873869.
Effects of neoadjuvant trastuzumab, pertuzumab and palbociclib on Ki67 in HER2 and ER-positive breast cancer.
Gianni L, Colleoni M, Bisagni G, Mansutti M, Zamagni C, Del Mastro L
NPJ Breast Cancer. 2022; 8(1):1.
PMID: 35013314
PMC: 8748500.
DOI: 10.1038/s41523-021-00377-8.
Epithelial Membrane Protein 2 Suppresses Non-Small Cell Lung Cancer Cell Growth by Inhibition of MAPK Pathway.
Ma Y, Schroder D, Nenkov M, Rizwan M, Abubrig M, Sonnemann J
Int J Mol Sci. 2021; 22(6).
PMID: 33799364
PMC: 7999101.
DOI: 10.3390/ijms22062944.
Cancer metastasis as a non-healing wound.
Deyell M, Garris C, Laughney A
Br J Cancer. 2021; 124(9):1491-1502.
PMID: 33731858
PMC: 8076293.
DOI: 10.1038/s41416-021-01309-w.
GDF-5 promotes epidermal stem cells proliferation via Foxg1-cyclin D1 signaling.
Zhao X, Bian R, Wang F, Wang Y, Li X, Guo Y
Stem Cell Res Ther. 2021; 12(1):42.
PMID: 33413682
PMC: 7792190.
DOI: 10.1186/s13287-020-02106-7.
Transcriptional down-regulation of metabolic genes by Gdown1 ablation induces quiescent cell re-entry into the cell cycle.
Jishage M, Ito K, Chu C, Wang X, Yamaji M, Roeder R
Genes Dev. 2020; 34(11-12):767-784.
PMID: 32381628
PMC: 7263145.
DOI: 10.1101/gad.337683.120.
Tumour kinome re-wiring governs resistance to palbociclib in oestrogen receptor positive breast cancers, highlighting new therapeutic modalities.
Pancholi S, Ribas R, Simigdala N, Schuster E, Nikitorowicz-Buniak J, Ressa A
Oncogene. 2020; 39(25):4781-4797.
PMID: 32307447
PMC: 7299844.
DOI: 10.1038/s41388-020-1284-6.
miR‑378 in combination with ultrasonic irradiation and SonoVue microbubbles transfection inhibits hepatoma cell growth.
Wang J, Li Y, Ma Q, Huang J
Mol Med Rep. 2020; 21(6):2493-2501.
PMID: 32236628
PMC: 7185276.
DOI: 10.3892/mmr.2020.11045.
Screening, identification and validation of CCND1 and PECAM1/CD31 for predicting prognosis in renal cell carcinoma patients.
Yang J, Shi S, Xu W, Qiu Y, Zheng J, Yu K
Aging (Albany NY). 2019; 11(24):12057-12079.
PMID: 31850854
PMC: 6949065.
DOI: 10.18632/aging.102540.
Systematic identification of key genes and pathways in clear cell renal cell carcinoma on bioinformatics analysis.
Tian Z, Yuan C, Yang K, Gao X
Ann Transl Med. 2019; 7(5):89.
PMID: 31019939
PMC: 6462636.
DOI: 10.21037/atm.2019.01.18.
Tumor-Associated Macrophages Induce Endocrine Therapy Resistance in ER+ Breast Cancer Cells.
Castellaro A, Rodriguez-Baili M, Di Tada C, Gil G
Cancers (Basel). 2019; 11(2).
PMID: 30736340
PMC: 6406935.
DOI: 10.3390/cancers11020189.
Hsa-miR-376c-3p targets Cyclin D1 and induces G1-cell cycle arrest in neuroblastoma cells.
Bhavsar S, Lokke C, Flaegstad T, Einvik C
Oncol Lett. 2018; 16(5):6786-6794.
PMID: 30405823
PMC: 6202480.
DOI: 10.3892/ol.2018.9431.